Morning Breakouts

Latest KFF Health News Stories

More Countries Investigate AstraZeneca

Morning Briefing

Reports of blood clotting side effects persist with AstraZeneca vaccine. In other global health news, the U.K. considers vaccine passports, India hits 100,000 covid cases a day, and Russia’s covid toll is likely higher than first reported.

Collapsing Toxic Waste Reservoir Threatens Hundreds In Florida

Morning Briefing

In other news across the states, West Virginia moves to protect doctors from liability in abortion-stopping treatment, officials in Indiana try to trace potential covid infections from an NCAA tournament, and covid is gone from California’s nursing homes.

Health Care Workers Feel Beleaguered

Morning Briefing

The pandemic continues to take a toll on health care workers. One survey says 21% of health care workers have considered quitting. In other health care industry news, 10% of black patients report discrimination in their health care. And rich hospitals got richer in the pandemic.

Covid Vaccines Safe In Pregnancy; Women Report More Side Effects

Morning Briefing

Separate studies say that covid vaccines are safe in pregnancy and breastfeeding, and may benefit the baby. Also, women are reporting many more experiences with vaccine side effects than men, possibly for reasons relating to biology.

DeSantis Denies Any Wrongdoing Over Vaccine Partnership With Publix

Morning Briefing

Campaign finance records show that the company gave $100,000 to the Florida governor’s political action committee weeks before it scored a deal to distribute the covid vaccine, “60 Minutes” reported.

Can You Design A Better Face Mask?

Morning Briefing

The Biden administration intends to give half a million dollars to someone who designs a mask that fits better. Maybe one that doesn’t fog up eyeglasses? The Biden administration is also facing renewed calls to delay second vaccine doses in order to get more Americans at least one dose sooner.

Johnson & Johnson Testing Vaccine On Teens

Morning Briefing

The Biden administration put the company in charge of its own manufacturing after a contractor ruined 15 million doses. The company’s one-shot covid vaccine has become the favorite among groups reaching the homeless.

Protective Gear Prices Remain High

Morning Briefing

Prices for protective gear remain high as hospitals build inventories to a 45-day supply. In other heath care industry news, Seema Verma joins the board of a health tech company and anesthesiologists in two states accuse UnitedHealthcare of stifling competition.

Medicare Beneficiaries With Wanderlust Are Encouraged To Make Sure Their Coverage Travels, Too

Morning Briefing

It appears likely that vaccinated seniors will be ready to hit the road but CNBC offers the caution that before travelling, they should check the specifics of their insurance regarding emergency and routine care. Meanwhile, in a separate story, Becker’s reports a rise in people waiting until they are eligible for Medicare seeking medical care.

Why The US Didn’t Seek Patents On Gilead Drug Remdesivir

Morning Briefing

The federal government declined to seek patents on remdesivir, which brought in $2.8 million in revenue to Gilead in a single year. Hydroxychloroquine is still being used to fight covid despite the lack of evidence it does anything. And more studies on long-haul covid.